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Low yields of blood and urine.
GNB were isolated more frequently.
Low mortality
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Background: Infection with HIV-1 has been considered
n important co-factor in the development of Kaposi’s sar-
oma (KS), and antiretroviral therapy (ARV) has proven to
e beneﬁt to diminish KS-AIDS worldwide. In many African
ountries, KS has risen dramatically since the onset of the
IDS epidemic. Human herpesvirus 8 (HHV-8) is the etiolog-
cal agent of KS. In Mozambique, no large study on HHV-8
nfection has been conducted yet. The present study aimed
o: (i) present and compare the frequencies and titers of
HV-8 antibodies in serum samples of KS and non-KS indi-
iduals from Mozambique, (ii) identify variables associated
ith HHV-8 infection, and (iii) search for predictive markers
or KS development.
Methods: In-house immunoﬂuorescence assays were
mployed for HHV-8 antibody detection in sera from indi-
iduals seen at public health centers in Northern (n=208),
entral (n=226), and Southern (n=318) Mozambique, and in
4 KS patients. HIV serology was used for comparative anal-
sis. Socioeconomic, demographic and clinical data were
ssessed by interview. The study was approved by all par-
icipant institutions.
Results: The overall frequency of HHV-8 antibodies was
1.4% and, in spite of the diversity of epidemiological
haracteristics of the tested individuals, did not differ signif-
cantly among regions: 18.7%, 24.3% and 21.4% in Northern,
entral and Southern Mozambique, respectively (X2, 2.37;
=0.305). The variables that were signiﬁcantly associated
ith the presence of HHV-8 antibodies were gender, age,
evel of education, number of siblings and HIV serostatus,
ut these differed across the regions. The overall prevalence
f HHV-8 seropositivity increased with age. High titers of
HV-8 antibodies also against latent antigens were detected
n KS patients and in non-KS individuals co-infected with HIV-
, and this increased titer could have predictive value. Large
umber of participants (30% to 50%) unknown its real HIV
erostatus, thus they were not under ARV therapy.
Conclusion: These results demonstrate that Mozam-
ique is another country in Africa with endemic HHV-8
nfection and that, because of the AIDS epidemic sug-
ests universal access to antiretroviral treatment to avoid
n outbreak of AIDS-KS. Support: CNPq (PROAFRICA grant
umber 490452/2007-8), fellowship to ACA (grant number
04372/2006-4), and Instituto Adolfo Lutz (CTC 55/06)
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Background: Neutropenia is one of the most com-
on hematologic manifestations in HIVinfected individuals,
resent in 5-10% in early stages and more than 50% in
dvanced stages of the disease. Most of the data reported
y SFN emerge from the analysis of cancer patients, did not
now of speciﬁc data on HIV.
Objective: To determine the clinic-epidemiological and
tiological SFN episodes in HIV / AIDS.
Methods: Prospective analytic study developed from June
007 until October 2009, at the Hospital Rawson.
Inclusion criteria: conﬁrmed HIV infection, more severe
eutropenia (500 total neutrophils less), plus fever
T>38 ◦C).
Results: We recruited 18 patients with 22 episodes of
FN, the average age was 38.4%. 36.3% male. A single
atient presented other comorbidities associated: chronic
CV infection. Probable causes of SFN (n: 22): Chemother-
py for NHL 5 (22.7%), disseminated mycosis 5 (22.7%). In
4.5% found only associated with drug toxicity as a likely
ause, although it was present in all cases. In 59.1% of
pisodes the SFN was the cause of hospitalization. The 68.2%
ad pancytopenia. Probable origin of infection: respiratory
5.4%, 36.3% gastrointestinal, skin and soft tissue 27.3%,
haryngeal and odontogenic 18.1%, urinary tract 18.1%,
etinitis 9%, and unfocused clinical 9%.The CD4 count was
ess than 200 in 19 episodes (86.3%). The average duration
f neutropenia and fever was 7.6 and 9 days respectively. Of
ll episodes, 7 (31.8%) had microbiological isolation. Bacte-
ial 5 (71.4%): GNB 4 and Gram-positive cocci 1. Fungi were
solated in 2 episodes (28.5%): 1 Cryptococcus and Histo-
lasma 1. Microbiological performance of the methods of
iagnosis: 17.8% blood cultures, urine cultures 8.7%, bone
arrow puncture 22.2%, CSF culture 20% lysis-centrifugation
lood cultures by 6.6%. More empirical treatments used:
iperacillin / tazobactam 31.8%, piperacillin and amikacin,
7.2%. Mortality was 18.2%. Bacteremia was associated with
50% mortality.
Conclusion: Predominance in young males.
High frequency of severe neutropenia related only to drug
oxicity.
